Four teeth in the CH-IPT group and one tooth in the 3Mix-MP group were radiographic failures. One tooth in each group showed pulp canal obliteration (PCO), which was not regarded as a radiographic failure. The types of radiographic failures found at the 6–11 month recall are shown in Table 3. Partial thickening of the periodontal space at the bifurcation was observed in two and four teeth of the CH-IPT and 3Mix-MP groups, respectively. One tooth in the CH-IPT group and two teeth in the 3Mix-MP group showed partial loss of the lamina dura. All of these were classified into Selleckchem AT9283 the observe group (Table 3). Treatment success at the 6–11 recall for the mandibular

first and second primary molars treated with CH-IPT and 3Mix-MP, respectively, from Fig. 1a are presented in Fig. 1b and that of the CH-IPT-treated mandibular first primary molar from Fig. 2a is seen in Fig. 2b. There was no statistically significant difference between overall success rates of the CH-IPT group or 3Mix-MP group at the 6–11 month recall (P = 0.91, Pearson chi-square). At the 12–29 month recall (mean = 22.81 ± 5.52 months), 72 of 82 teeth were available for a second evaluation. Six of 41 teeth in the CH-IPT group (15%) and 4 of 41 teeth (10%) in the 3Mix-MP group were dropped out. The distribution of teeth

seen at 12–29 months according to tooth Crizotinib research buy type and treatment group is shown in Table 1. Thirty-five of 35 teeth (100%) in the CH-IPT group and 35 of 37 teeth (95%) teeth in the 3Mix-MP group showed clinical success, whereas 33 of 35

teeth (94%) in the CH-IPT group and 30 of 37 teeth (81%) in the 3Mix-MP group showed radiographic success. PCO was found in seven teeth (20%) and eleven teeth (30%) in the CH-IPT and 3Mix-MP groups, respectively. The types of clinical and radiographic failures found at the 12–29 month recall are shown in Table 4. Of the teeth put into the ‘observed’ group, one of three IPT-treated teeth was deemed a failure, and all six 3Mix-MP-treated teeth were found to be successes. Examples of successful cases at 14-months for mandibular first and second primary molars treated with CH-IPT and 3Mix-MP, respectively, are seen in Fig. 1c. Although pulpal obliteration Phosphoglycerate kinase was observed in the CH-IPT-treated tooth, this was not a criterion for failure. A treatment failure at 25-months for a CH-IPT-treated mandibular first primary molar, due to internal resorption perforating the mesial root, is seen in Fig. 2c. Thirty-three of 35 teeth (94%) in the CH-IPT group and 29 of 37 teeth (78%) in the 3Mix-MP group showed overall treatment success. At the 12–29 month recall, there was no statistically significant difference between the overall success rates of CH-IPT or 3Mix-MP groups for the treatment of deep caries approaching the pulp in mandibular primary molars (P value = 0.08, Fisher,s Exact). (Table 2).